Literature DB >> 2035525

Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers.

R I Richards1, Y Shen, K Holman, H Kozman, V J Hyland, J C Mulley, G R Sutherland.   

Abstract

We describe two highly polymorphic microsatellite AC repeat sequences, VK23AC and VK14AC, which are closely linked to the fragile X at Xq27.3. Both VK23AC (DXS297) and VK14AC (DXS292) are proximal to the fragile site. Two-point linkage analysis in 31 fragile X families gave (a) a recombination frequency of 1% (range 0.00%-4%) with a maximum lod score of 32.04 for DXS297 and (b) a recombination frequency of 7% (range of 3%-15%) with a maximum lod score of 12.87 for DXS292. Both of these polymorphisms are applicable to diagnosis by linkage in families with fragile X syndrome. A multipoint linkage map of genetic markers at Xq27.3 was constructed from genotyping these polymorphisms in the CEPH pedigrees. The DXS292 marker is in the DXS98-DXS297 interval and in 3 cM proximal to DXS297.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035525      PMCID: PMC1683096     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome.

Authors:  J Dausset; H Cann; D Cohen; M Lathrop; J M Lalouel; R White
Journal:  Genomics       Date:  1990-03       Impact factor: 5.736

2.  Assignment of anonymous DNA probes to specific intervals of human chromosomes 16 and X.

Authors:  V J Hyland; K E Fernandez; D F Callen; R N MacKinnon; E Baker; K Friend; G R Sutherland
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

3.  Report of the Committee on Methods of Linkage Analysis and Reporting.

Authors:  P M Conneally; J H Edwards; K K Kidd; J M Lalouel; N E Morton; J Ott; R White
Journal:  Cytogenet Cell Genet       Date:  1985

4.  Linkage between the fragile X and F9, DXS52 (St14), DXS98 (4D-8) and DXS105 (cX55.7).

Authors:  J Mulley; G Turner; S Bain; G R Sutherland
Journal:  Am J Med Genet       Date:  1988 May-Jun

5.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

6.  Genetic mapping of new RFLPs at Xq27-q28.

Authors:  G K Suthers; I Oberlé; J Nancarrow; J C Mulley; V J Hyland; P J Wilson; J McCure; C P Morris; J J Hopwood; J L Mandel
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

7.  Genetic analysis of the fragile-X mental retardation syndrome with two flanking polymorphic DNA markers.

Authors:  I Oberlé; R Heilig; J P Moisan; C Kloepfer; G M Mattéi; J F Mattéi; J Boué; U Froster-Iskenius; P A Jacobs; G M Lathrop
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene.

Authors:  M Litt; J A Luty
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

9.  The common fragile site in band q27 of the human X chromosome is not coincident with the fragile X.

Authors:  G R Sutherland; E Baker
Journal:  Clin Genet       Date:  1990-03       Impact factor: 4.438

Review 10.  Diagnostic molecular genetics of the fragile X.

Authors:  G R Sutherland; J C Mulley
Journal:  Clin Genet       Date:  1990-01       Impact factor: 4.438

View more
  18 in total

Review 1.  Molecular analysis of the fragile X syndrome.

Authors:  M C Hirst; S M Knight; Y Nakahori; A Roche; K E Davies
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome.

Authors:  J T Clarke; P J Wilson; C P Morris; J J Hopwood; R I Richards; G R Sutherland; P N Ray
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

3.  Nucleosomal occupancy and CGG repeat expansion: a comparative analysis of triplet repeat region from mouse and human fragile X mental retardation gene 1.

Authors:  Sonal Datta; Mohammad Parwez Alam; Subeer S Majumdar; Abhishek Kumar Mehta; Souvik Maiti; Neerja Wadhwa; Vani Brahmachari
Journal:  Chromosome Res       Date:  2011-04-16       Impact factor: 5.239

4.  Dinucleotide repeat polymorphisms at the DXS294 and DXS300 loci in Xq26.

Authors:  A K Gedeon; R I Richards; J C Mulley
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

5.  Dinucleotide repeat polymorphism at the D16S288 locus.

Authors:  Y Shen; K Holman; A Thompson; H Kozman; D F Callen; G R Sutherland; R I Richards
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

6.  An STS at the D16S290 locus.

Authors:  L Z Chen; Y Shen; K Holman; A Thompson; S Lane; R I Richards; G R Sutherland; D F Callen
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

7.  Fragile-X syndrome: unique genetics of the heritable unstable element.

Authors:  S Yu; J Mulley; D Loesch; G Turner; A Donnelly; A Gedeon; D Hillen; E Kremer; M Lynch; M Pritchard
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

8.  X-linked recessive panhypopituitarism associated with a regional duplication in Xq25-q26.

Authors:  M Lagerström-Fermér; M Sundvall; E Johnsen; G L Warne; S M Forrest; J D Zajac; A Rickards; D Ravine; U Landegren; U Pettersson
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

9.  Isolation of a human DNA sequence which spans the fragile X.

Authors:  E J Kremer; S Yu; M Pritchard; R Nagaraja; D Heitz; M Lynch; E Baker; V J Hyland; R D Little; M Wada
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

10.  Molecular carrier testing for the fragile X syndrome: Issues for genetic counselors.

Authors:  J L Berliner; F N Shapiro; S L Nolin; G E Houck; X H Ding; C Dobkin; S S Brooks; W T Brown
Journal:  J Genet Couns       Date:  1994-09       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.